These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14702835)

  • 1. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.
    Raso G; N'Goran EK; Toty A; Luginbühl A; Adjoua CA; Tian-Bi NT; Bogoch II; Vounatsou P; Tanner M; Utzinger J
    Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):18-27. PubMed ID: 14702835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
    Assaré RK; Tian-Bi YN; Yao PK; N'Guessan NA; Ouattara M; Yapi A; Coulibaly JT; Meïté A; Hürlimann E; Knopp S; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004329. PubMed ID: 26789749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
    N'Goran EK; Gnaka HN; Tanner M; Utzinger J
    Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d'Ivoire: a SCORE study protocol.
    Assaré RK; Knopp S; N'Guessan NA; Yapi A; Tian-Bi YN; Yao PK; Coulibaly JT; Ouattara M; Meïté A; Fenwick A; N'Goran EK; Utzinger J
    BMC Public Health; 2014 Dec; 14():1290. PubMed ID: 25519880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of the Point-of-Care Circulating Cathodic Antigen Urine Cassette Test for Diagnosis of
    Assaré RK; Tra MBI; Ouattara M; Hürlimann E; Coulibaly JT; N'Goran EK; Utzinger J
    Am J Trop Med Hyg; 2018 Dec; 99(6):1567-1572. PubMed ID: 30277203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in the prevalence and intensity of hookworm infections after praziquantel treatment for schistosomiasis infection.
    Utzinger J; Vounatsou P; N'Goran EK; Tanner M; Booth M
    Int J Parasitol; 2002 Jun; 32(6):759-65. PubMed ID: 12062494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire.
    Utzinger J; N'Goran EK; Esse Aya CM; Acka Adjoua C; Lohourignon KL; Tanner M; Lengeler C
    Trop Med Int Health; 1998 Sep; 3(9):711-20. PubMed ID: 9754666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
    N'Goran EK; Odiere MR; Assandé Aka R; Ouattara M; Aka NAD; Ogutu B; Rawago F; Bagchus WM; Bödding M; Kourany-Lefoll E; Tappert A; Yin X; Bezuidenhout D; Badenhorst H; Huber E; Dälken B; Haj-Ali Saflo O
    Lancet Infect Dis; 2023 Jul; 23(7):867-876. PubMed ID: 36893784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial.
    Coulibaly JT; Panic G; Silué KD; Kovač J; Hattendorf J; Keiser J
    Lancet Glob Health; 2017 Jul; 5(7):e688-e698. PubMed ID: 28619227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'Ivoire.
    Chammartin F; Houngbedji CA; Hürlimann E; Yapi RB; Silué KD; Soro G; Kouamé FN; N Goran EK; Utzinger J; Raso G; Vounatsou P
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3407. PubMed ID: 25522007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
    Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO; Rawago FO; Makworo NK; Muok EMO
    Parasit Vectors; 2024 Jun; 17(1):279. PubMed ID: 38943214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Schistosoma mono- and co-infections with multiple common parasites and associated risk factors and morbidity profile among adults in the Taabo health and demographic surveillance system, South-Central Côte d'Ivoire.
    Bassa FK; Eze IC; Assaré RK; Essé C; Koné S; Acka F; Laubhouet-Koffi V; Kouassi D; Bonfoh B; Utzinger J; N'Goran EK
    Infect Dis Poverty; 2022 Jan; 11(1):3. PubMed ID: 34983662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.